The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone shares his reaction to data that has been published and what needs to be researched going forward.
Results from a recently published study led by Shadi Yaghi, MD, and colleagues revealed that of 3556 participants, 0.9% of patients hospitalized with a diagnosis of COVID-19 had imaging proven ischemic stroke.
Mounting evidence from previous studies suggests that patients affected by the illness may develop clinically significant coagulopathy with thromboembolic complications. Yagdhi, an assistant professor and the director of Clinical Vascular Neurology Research at NYU Langone, claims there needs to be additional prospective studies and patients with COVID-19 need to be followed to fully understand how it may impact stroke on a daily basis.
In an interview with NeurologyLive, Yaghi dives into the specific measures needed to take in order to better understand the correlation between stroke and COVID-19. He also stresses the importance of testing patients for neurological complications during an in-hospital setting.
Yaghi, S, Koto I, Torres J, et al. Stroke. 2020;51:00—00. doi: 10.1161/STROKEAHA.120.030335